FDA Approved: SUMATRIPTAN SUCCINATE — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved Fresenius Kabi USA, LLC's sumatriptan succinate as an Original Application (ANDA), establishing a generic equivalent for treating acute migraine at…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sumatriptan succinate (Sumatriptan succinate)

Snippet

ORIG AP for SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE)